Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens

Pokaż inne wersje (1)

Adenoviruses are potent vectors for inducing and boosting cellular immunity to encoded recombinant antigens. However, the widespread seroprevalence of neutralizing antibodies to common human adenovirus serotypes limits their use. Simian adenoviruses do not suffer from the same drawbacks. We have con...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Antrobus, R, Coughlan, L, Berthoud, T, Dicks, MD, Hill, A, Lambe, T, Gilbert, S
Format:	Journal article
Język:	English
Wydane:	Nature Publishing Group 2014

Podobne zapisy

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
od: Antrobus, R, i wsp.
Wydane: (2014)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
od: Folegatti, P, i wsp.
Wydane: (2019)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
od: Pedro M. Folegatti, i wsp.
Wydane: (2019-05-01)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
od: Zhang, C, i wsp.
Wydane: (2023)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
od: Cheng Zhang, i wsp.
Wydane: (2023-06-01)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
od: Adam Berg, i wsp.
Wydane: (2021-10-01)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
od: Dicks, M, i wsp.
Wydane: (2015)

Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
od: Charlotte Davis, i wsp.
Wydane: (2024-06-01)

Combined intranasal and intramuscular parainfluenza 5-, simian adenovirus ChAdOx1- and poxvirus MVA-vectored vaccines induce synergistically HIV-1-specific T cells in the mucosa
od: Ashley C. Beavis, i wsp.
Wydane: (2023-07-01)

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
od: O'Hara, G, i wsp.
Wydane: (2012)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
od: Hermosilla, E, i wsp.
Wydane: (2022)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
od: Eduardo Hermosilla, i wsp.
Wydane: (2022-03-01)

CMV-associated T cell and NK cell terminal differentiation does not impact immunogenicity of ChAdOx1 vaccination
od: Sharpe, HR, i wsp.
Wydane: (2022)

Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity
od: Jinnam Kim, i wsp.
Wydane: (2023-04-01)

A rare case of bilateral optic neuritis post-Covishield (ChAdOx1-S [recombinant]) vaccination
od: Tanie Natung, i wsp.
Wydane: (2023-01-01)

CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination
od: Hannah R. Sharpe, i wsp.
Wydane: (2022-03-01)

Herpes zoster following vaccination with ChAdOx1 nCoV-19 Coronavirus vaccine (recombinant)
od: Anupa Mary Job, i wsp.
Wydane: (2022-01-01)

Durability of ChAdOx1 nCov-19 vaccination in people living with HIV
od: Ogbe, A, i wsp.
Wydane: (2022)

Clinical assessment of ChAdOx1 vectored vaccines against emerging pathogens
od: Moreira Folegatti, P
Wydane: (2021)

Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S
od: Bas de Laat, i wsp.
Wydane: (2022-07-01)

Thromboses of major arteries and ChAdOx1 nCov-19 vaccination
od: Rujittika Mungmunpuntipantip, i wsp.
Wydane: (2021-11-01)

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
od: Ane Ogbe, i wsp.
Wydane: (2022-04-01)

ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
od: Alharbi, N, i wsp.
Wydane: (2017)

Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats
od: Stedman, A, i wsp.
Wydane: (2019)

Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
od: Simone Barocci, i wsp.
Wydane: (2022-03-01)

Humoral immunogenicity and efficacy of a single dose of ChAdOx1 MERS vaccine candidate in dromedary camels
od: Alharbi, N, i wsp.
Wydane: (2019)

Simian adenoviruses as vaccine vectors
od: Morris, S, i wsp.
Wydane: (2016)

Simian adenoviruses as vaccine vectors
od: Morris, S, i wsp.
Wydane: (2016)

Widespread Arterial Thrombosis after ChAdOx1 nCov-19 Vaccination
od: Giorgio Berlot, i wsp.
Wydane: (2022-01-01)

Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine
od: Lea Krutzke, i wsp.
Wydane: (2022-07-01)

LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination
od: Tamara Garibashvili, i wsp.
Wydane: (2022-06-01)

Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles.
od: Jennifer Serwanga, i wsp.
Wydane: (2024-01-01)

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a Phase 1/2 clinical trial
od: Ewer, K, i wsp.
Wydane: (2020)

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
od: Marchevsky, NG, i wsp.
Wydane: (2022)

Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine
od: Edmund G.-T. Wee, i wsp.
Wydane: (2024-08-01)

ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys
od: Neeltje van Doremalen, i wsp.
Wydane: (2022-12-01)

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
od: Natalie Gabrielle Marchevsky, i wsp.
Wydane: (2022-07-01)

ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface
od: Tao Ni, i wsp.
Wydane: (2023-10-01)

IgA Vasculitis Following ChAdOx1 nCoV-19 Vaccination
od: Manabendra Basu, i wsp.
Wydane: (2024-01-01)

DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination
od: Gerardo Casucci, i wsp.
Wydane: (2021-06-01)